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Outer Membrane Vesicles (OMVs) derived from different Gram-negative bacteria
have been proposed as an attractive vaccine platform because of their own
immunogenic adjuvant properties. Pertussis or whooping cough is a highly contagious
vaccine-preventable respiratory disease that resurged during the last decades in many
countries. In response to the epidemiological situation, new boosters have been
incorporated into vaccination schedules worldwide and new vaccine candidates have
started to be designed. Particularly, our group designed a new pertussis vaccine
candidate based on OMVs derived from Bordetella pertussis (BpOMVs). To continue
with the characterization of the immune response induced by our OMV based
vaccine candidate, this work aimed to investigate the ability of OMVs to activate the
inflammasome pathway in macrophages. We observed that NLRP3, caspase-1/11, and
gasdermin-D (GSDMD) are involved in inflammasome activation by BpOMVs. Moreover,
we demonstrated that BpOMVs as well as transfected B. pertussis lipooligosaccharide
(BpLOS) induce caspase-11 (Casp11) and guanylate-binding proteins (GBPs) dependent
non-canonical inflammasome activation. Our results elucidate the mechanism by which
BpOMVs trigger one central pathway of the innate response activation that is expected
to skew the adaptive immune response elicited by BpOMVs vaccination.
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INTRODUCTION
Outer membrane vesicles (OMVs) are nano-structures that are released spontaneously from the
cell envelope of Gram-negative bacteria (1). OMVs are typically 50–200 nm in diameter, and are
produced during different growth phases and in several environmental conditions studied to date
(2). OMVs from some microorganisms are also able to deliver a diversity of virulence factors,
including toxins, adhesins, and cell wall components such as peptidoglycan and lipopolysaccharide
(LPS), immunomodulatory molecules directly into host cells during infection (3–8). Owing to their
adaptability as a delivery vehicle, the contributions of OMVs to bacterial fitness are diverse, but
there is increasing interest on their role in host colonization and disease pathogenesis (9, 10). These
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features and the intrinsic adjuvant capacity render OMVs
as promising candidates for vaccine development against
bacterial infections (11, 12). Despite their prophylactic potential
there are few studies exploring the direct effects of OMVs
on monocytes/macrophages and inflammasome activation.
Inflammasomes are multiprotein complexes that assemble
in the cytosol of different epithelial and immune cells,
particularly in macrophages, and involve different sensors
and caspases (13). Using the Bordetella pertussis (etiologic
agent of the respiratory disease named pertussis) in vitro
infection model there is evidence of inflammasome activation
in human and murine macrophages and, the protective IL-1β
response was demonstrated to be caspase-1-independent (14,
15). IL-1β production in mouse dendritic cells is triggered by
B. pertussis virulence factor adenylate cyclase, through NLRP3
cytosolic sensor and consequent activation of caspase-1. This
inflammasome activation leads to an antigen specific Th17
response in the murine infection model (16, 17). Activation of
the inflammatory caspase-1 by detection of Danger-Associated
Molecular Patterns (DAMPs) or Pathogen Associated Molecular
Patterns (PAMPs) by different cytosolic inflammasome sensors
triggers the processing of the pro-forms of interleukin IL-1β
and IL-18 with their subsequent release to the extracellular
milieu. This capase-1 dependent process is termed as “canonical”
inflammasome activation. A “non-canonical” inflammasome
activation has been described as a pathway that is dependent
on caspase-11 (in mice) or caspase-4/5 (in humans). These
inflammatory caspases can sense intracellular LPS from gram-
negative bacteria and together with caspase-1 can cleave the pore
forming protein gasdermin-D (GSDMD). GSDMDpermeabilizes
the cell membrane and may trigger pyroptosis, a form of
inflammatory programmed cell death. However, release of IL-1β
and IL-1α cytokines is feasible in the absence of cell lysis
through GSDMD pores, likewise the release of high mobility
group box 1 (HMGB1) alarmin molecules and even the entire
inflammasome complexes including caspase-1 (18–20). The
inflammatory cytokine IL-1β is an endogenous mediator that
modulate immunity in the host and is involved in the induction
of a Th17/Th1 profile in vivo in response to pathogens (21).
Pertussis or whooping cough is a highly contagious vaccine-
preventable respiratory disease. Infant immunization programs
with pertussis vaccines have been vastly successful in preventing
the severe disease (22). However, in recent years the disease
has reemerged in communities/states/countries with a striking
high number of cases (23, 24). Multiple factors that could
explicate the resurgence of the disease have been proposed,
most of them related to present-day vaccines: waning vaccine-
induced immunity, the switch from whole cell vaccines (wP)
to acellular vaccines (aP) and pathogen adaptation (25–27). We
have developed a new acellular anti-pertussis vaccine candidate
based on OMVs derived from B. pertussis (BpOMVs) that has
similarities with the main relevant properties of current aP
vaccines in terms of biosafety and those of wP vaccines in terms
of immunogenicity and protective capacity (28, 29).
In the present study, we show that BpOMVs are capable of
triggering inflammasome activation in murine and in human
macrophage cells. We characterized the mechanism by which
BpOMVs trigger inflammasome activation, showing that IL-
1β production by BpOMVs is dependent on canonical NLRP3
inflammasome and the adaptor molecule ASC [Apoptosis-
associated speck-like protein containing a caspase recruitment
domain (CARD)]. Moreover, we demonstrated that BpOMVs
as well as transfected Bordetella pertussis lipooligosaccharide
(BpLOS) induces caspase-11 (Casp11) dependent non-canonical
inflammasome activation and guanylate-binding proteins (GBP)




Isolation of Outer Membrane Vesicles (OMVs)
OMVs were isolated from bacterial cells as previously described
(28, 30). Briefly, culture samples from the decelerating growth
phase were centrifuged at 10,000 × g for 20min at 4◦C and
the bacterial pellet obtained was resuspended in 20mM Tris–
HCl, 2mM EDTA pH 8.5 (TE buffer). Five milliliters of TE
buffer were used to resuspend approximately 1 g (wet weight) of
bacteria. The suspension was sonicated in cool water for 20min.
After two centrifugations at 10,000 × g for 20min at 4◦C, the
supernatant was pelleted at 100,000 × g for 2 h at 4◦C. This
pellet was resuspended in 1.5% (w/v) deoxycholate (DOC) in TE
buffer. Six milliliters of this suspension were added on 2ml of
sucrose 60% (w/v). After centrifugation at 100,000 × g for 2 h
at 4◦C, the OMV band was observed at TE/sucrose interphase.
The OMVs were stored with glycerol 1% and sodium azide
0.001%? at 4◦C. The samples obtained for all the B. pertussis
strains used were negatively stained and then examined with an
electron microscope.
Ethics Statement
All experiments involving animals were conducted in accordance
with the Brazilian Federal Law number 11.794, which regulates
the scientific use of animals in Brazil, the Institutional Animal
Care and Use Committees (IACUC) guidelines, and the Animal
Welfare Act and Regulations guidelines established by the
American Veterinary Medical Association Panel on Euthanasia.
Animals were fed, housed, and handled in strict agreement
with these recommendations. All protocols were approved by
the Committee for Ethics in Animal Experimentation (CETEA)
at Universidade Federal de Minas Gerais UFMG under permit
#165/2019. In Argentina, animals were fed, housed, and handled
in strict agreement with the recommendations, protocols, and
guidance of CICUAL (Institutional Committee for the Care and
Use of Laboratory Animals) with the approved protocol #005-06-
15 extended in validity until August 10, 2023.
Mice
In Brazil, wild-type C57BL/6 mice were purchased from the
Federal University of Minas Gerais (UFMG). Nlrp3−/− and
Casp1/11−/− were described previously and backcrossed to
C57BL/6 mice for at least eight generations (31, 32). Casp11−/−,
Gsdmd−/−, and Gbpchr3−/− mice were generated in the
C57BL/6 background (33–37). The animals were maintained at
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UFMG under 12 h cycles of light/dark and used at 6–9 week of
age. In Argentina, wild type C57BL/6 mice were purchased from
Laboratory of experimental animals, LAE- Faculty of Veterinary
Sciences of the National University of La Plata (UNLP).
Generation of Bone Marrow Derived Macrophages
(BMDM)
BM cells were obtained from femur and tibiae of knockout
(KO) and wild type (WT) mice, and they were differentiated
into BMDMs using a previously described protocol, with some
modifications (38). Briefly, cells were seeded on 24-well plates at
5 × 105 cell/mL (day 0) and maintained in Dulbecco’s Modified
Eagle Medium- DMEMmedium containing 10% FBS, 100 U/mL
penicillin, 100µg/mL streptomycin, and 20% L929-conditioned
medium (LCCM), at 37◦C in a 5% CO2 atmosphere for 7 days.
On day 4 of incubation, the medium was fully replaced.
In vitro Stimulation of BMDMs
In all experiments, BMDMs were maintained in DMEMmedium
containing 10% FBS. Cells were stimulated with BpOMVs
(800 ng/mL) or with free or transfected BpLOS [obtained and
purified at our lab as previously described (39)] (800 ng/mL)
in 0.5mL DMEM + 10% FBS, previously incubated with
indicated concentration of KCl for 1 h, where applicable. BpLOS
transfection was carried out with FuGENE R© HD Transfection
Reagent (Promega R©) according to manufacturer’s specifications.
Supernatants were collected at indicated times. Cells were then
washed with PBS at room temperature, lysed with 25 µL/well M-
PERR + 10mM NaF, 1mM sodium orthovanadate, and 1:100
protease inhibitors cocktail and collected in 1.5mL tubes. Both
supernatants and cell lysates were stored at−80◦C until use.
Western Blot Analysis
BMDM culture supernatants were collected, and cells were
lysed with M-PER Mammalian Protein Extraction Reagent
(Thermo Fisher Scientific) supplemented with 1:100 protease
inhibitor mixture (Sigma-Aldrich). Cell lysates and supernatants
were subjected to SDS-PAGE analysis and western blotting.
The proteins were resuspended in SDS containing loading
buffer, separated on a 15% SDS-PAGE gel, and transferred
to nitrocellulose membranes (Amersham Biosciences, Uppsala,
Sweden) in transfer buffer (50mM Tris, 40mM glycine, 10%
methanol). Membranes were blocked for 1 h in TBS with
0.1% Tween-20 containing 5% non-fat dry milk and incubated
overnight with primary antibodies at 4◦C. Primary Abs used
included amouse monoclonal against the p20 subunit of caspase-
1 (Adipogen, San Diego, CA, USA) and the p17 subunit of
IL-1β (Cell Signaling Technology, Danvers, MA) at a 1:1,000
dilution. Loading control blot was performed using mAb anti–
β-actin (Cell Signaling Technology, Danvers, MA) at a 1:1,000
dilution. The membranes were washed three times for 5min in
TBS with 0.1% Tween 20 and incubated for 1 h at 25◦C with
the appropriate HRP-conjugated secondary Ab (Cell Signaling
Technology, Danvers, MA) at a 1:1,000 dilution. Immunoreactive
bands were visualized using Luminol chemiluminescent HRP
substrate (Millipore) and analyzed using the ImageQuant TL
Software (GE Healthcare, Buckinghamshire, United Kingdom).
RNA Isolation From BMDMs and Quantitative
Real-Time PCR
Total RNA from stimulated BMDMs was isolated using the
TRIzol R© reagent, accordingly to manufacturer instructions.
Reverse transcription of 1 µg from total RNA was performed
using illustraTM Ready-To-Go RT-PCR Beads (GE Healthcare,
UK), following instructions of the manufacturer. Quantitative
real-time PCR was performed using SYBR Green PCR master
mix (Applied Biosystems, Foster City, CA) on a QuantStudio3
real-time PCR instrument (Applied Biosystems, Foster City,
CA). The specific primers to amplify fragments corresponding
to specific gene targets were used: β-actin, forward, 5′-GGC
TGTATTCCCCTCCATCG-3′, reverse, 5′-CCAGTTGGTAACA
ATGCCATGT-3′; GBP1, forward, 5′-GAGTACTCTCTGGAA
ATGGCCTCAGAAA-3′, reverse, TAGATGAAGGTGCTGCT
GAGGAGGACTG-3; GBP2, forward, 5′-CTGCACTATGTGA
CGGAGCTA-3′, reverse, 5′-CGG AATCGTCTACCCCACTC-
3′; GBP3, forward, 5′-CTGACAGTAAATCTGGAAGCCAT-3′,
reverse, 5′-CCGTCCTGCAAGACGATT CA-3′; GBP5, forward,
5′-CTGAACTCAGATTTTGTG CAGGA-3′, reverse, 5′-CAT
CGACATAAGTCAGCACCAG-3′; GBP7, forward, 5′-TCCTG
TGTGCCTAGTGGAAAA-3′, reverse, 5′-CAAGCGGTTCATC
AAGTAGGAT-3′. All data are presented as relative expression
units after normalization to the β-actin gene.Measurements were
conducted in triplicate.
Cell Line Stimulation
THP1-ASC-GFP (InvivoGen R©) were maintained in RPMI
medium containing 10% FBS, 100 U/mL penicillin, 100µg/mL
streptomycin at 37◦C in a 5% CO2 atmosphere and plated at
3.6 × 105 cells/well in 96-well plates. Cells were stimulated
with BpOMVs (800 ng/mL). For positive control stimulus, cells
were primed with ultrapure LPS from E. coli (Sigma-Aldrich)
1µg/mL (LPSE.coli) for 3 h and transfected with bacterial plasmid
cDNA (500 ng/mL). pcDNA was generated by cloning PCR-
generated full-length cDNA from a random non-related gene.
Transfection was carried out with LipofectamineTM LTX Reagent
with PLUSTM Reagent (Invitrogen) following manufacturer
instructions. Supernatants were harvested and stored at −80◦C
until use and cells were prepared for microscopy analysis.
THP1-XBlueTM-defMyD (InvivoGen R©) were maintained
in RPMI medium containing 10% FBS, 100 U/mL penicillin,
100µg/mL streptomycin at 37◦C in a 5% CO2 atmosphere
and plated at 1.8 × 105 cells/well in 96-well plates. Cells
were stimulated with BpOMVs (800 ng/mL). For positive
control stimulus, cells were stimulated with 50 ng/mL TNF-
α, as manufacturer recommendations. Supernatants were
harvested and stored at −80◦C until use for cytokines and
SEAP measurements.
Microscopy ASC-GFP Specks Observation
THP1-ASC-GFP cells were harvested after ON stimulation,
washed with PBS and centrifugated. Nuclei were DAPI stained
and 2% PFA fixation was performed. The number of ASC-GFP
positive cells and localization of fluorescent ASC specks were
determined using a Nikon Eclipse Ti Fluorescence Microscope
and analyzed with ImageJ. Every experimental condition was
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carried out in triplicated and three pictures per well were
taken. The relation between total cells and ASC-GFP specks was
calculated. The result shown in this study is the output of three
independent experiments.
Cytokine Determination in Supernatants by ELISA
Collected supernatants of stimulated BMDMs were thawed
on the day of the assay and used for determination of
mIL-1β, mIL-1α, mIL-12, and mTNF-α concentrations
using Mouse DuoSet ELISA (R&D Systems), according
to the manufacturer’s specifications. hIL-1β and hIL-8 in
supernatants of THP1 cells were measured using human
OptEIATM ELISA Set (BD), according to the manufacturer’s
specifications. hIL-18 in supernatants of THP1 cells were
measured using human IL-18 ELISA (eBioscience), according to
the manufacturer’s specifications.
Statistical Analysis
All experiments were repeated at least three times with
similar results. Graphs and data analysis were performed using
GraphPad Prism 6 (GraphPad Software), using one-way ANOVA
(Bonferroni post-hoc test) or Student’s t-test (Tukey’s post-hoc
test). All quantitative data are expressed as mean ± SEM. A P
< 0.05 (p ≤ 0.05) was considered statistically significant.
RESULTS
BpOMVs Induce IL-1β Secretion in
Unprimed Human and Murine
Macrophages and Partially Requires
Potassium Efflux
As a first approach to investigate the induction of IL-
1β secretion triggered by BpOMVs in BMDM and in a
human macrophage cell line (THP1), we performed a dose-
response assay to select the BpOMVs concentration to be
used along the different experiments. IL-1β levels, LDH values,
and morphological microscopy and flow cytometry analysis
were performed in order to select conditions with minimal
alterations on cell viability and significant cytokine secretion
(data not shown). In all cases, primed and unprimed murine
macrophages secreted significantly higher amounts of mIL-
1β (Figure 1A and Supplementary Figure 1) in response to
BpOMVs compared to control treatments (primed or NTC,
respectively). mTNF-α and mIL-6 were used as surrogate readout
FIGURE 1 | OMVs derived from B. pertussis (BpOMVs) triggers IL-1β in murine and human macrophages. (A) BMDM from C57BL/6 mice were stimulated ON with
BpOMVs previously treated or not with 80mM KCl for 30min, and mIL-1β was measured in supernatants. As positive control, cells were primed with LPSE.coli and
treated with Nigericin for 3 h. (B) THP1 cells were stimulated ON with BpOMVs. As a positive control, cells were primed with LPSE.coli for 3 h, then incubated ON with
ATP. hIL-1β, hIL-18, and hIL-8 were measured in supernatants by ELISA. (C) THP1-XBlue-defMy88 cells were stimulated ON with BpOMVs. As a positive control cells
were treated with TNF-α. *A result significantly different (p < 0.05) from NTC; #a result significantly different from BpOMVs stimulation (p ≤ 0.05).
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of NF-κB pathway activation and their secretion was increased
either by BpOMVs treatment as well as by priming with
LPSE.coli, as expected (Supplementary Figure 1). Secretion of
the proinflammatory cytokines IL-1β and IL-18 depends on the
activation of inflammasome multiprotein platforms. Although
different cytosolic sensor proteins may trigger inflammasome
assembly, the NLRP3 complex has been the most studied
to date (40). In this inflammasome pathway, the activation
mechanism is linked to membrane permeabilization and K+
efflux (41). To test whether potassium efflux is involved in
BpOMVs-induced inflammasome activation, high extracellular
concentration of K+ that inhibit its efflux from the cytosol
was used to treat BMDMs. The addition of 80mM KCl
to the macrophages prior to BpOMVs stimulus reduced
mIL-1β secretion (Figure 1A, p ≤ 0.05) without significant
changes in the inflammasome-independent cytokine mTNF-
α secretion (Supplementary Figure 1A), indicating that mIL-
1β secretion induced by BpOMVs partially requires potassium
efflux upstream NLRP3 to be activated. The induction of
hIL-1β and hIL-18 secretion triggered by BpOMVs was also
detected in human macrophages cells (THP1). Whereas, LPSE.coli
stimulates hIL-8 secretion at the same level of BpOMVs, it is
no able to induce hIL-1β and hIL-18 secretion (Figure 1B, p ≤
0.05). Inflammasome activation is considered to be a two-step
process: priming and activation (42). To evaluate the role of
MyD88 [a canonical adaptor of inflammatory signaling pathways
downstream members of the Toll-like receptor (TLRs) family] in
priming, THP1 XBlueTM MyD88Def cells were stimulated with
BpOMVs. hIL1-β and hIL-8 secretion was completely abolished
in Myd88 deficient cells (Figure 1C, p ≤ 0.05). SEAP (secreted
alkaline phosphatase) activity in supernatants was determined as
a control of NF-κB- and AP-1 stimulation in THP1-XBlueTM-
defMyD cells, indicating the incapacity of BpOMVs to trigger
these pathways in this cell line (Supplementary Figure 1B).
Conversely, hTNFα treatment used as control could induce hIL-
8 and SEAP secretion (Supplementary Figure 1B). Canonical
FIGURE 2 | OMVs derived from B. pertussis (BpOMVs) triggers ASC speck formation in THP1-ASC-GFP cells. (A) THP1-ASC-GFP cells were stimulated ON with
BpOMVs. Transfected LPSE.coli was used as a positive control for NLRP3 pathway. Cells were primed with LPSE.coli for 3 h, medium fully replaced and transfected with
pcDNA ON as a positive control for optimal visualization of specks. GFP-ASC specks were counted and the relation to total cells calculated. Data on graph show a
representative experiment. Three independent experiments were performed. Each point represents average number of total speck/total cells per field. Three fields of
each treatment were counted (2 replicates/treatment). *A result significantly different (*p ≤ 0.05) to NTC (B). Representative microscopy pictures from (A) are shown.
White arrowheads indicate the ASC-GFP. (C) hIL-1β, hIL-18, and hIL-8 were measured in supernatants by ELISA. Data are represented as mean ± SEM of three
replicates. *A result significantly different (*p ≤ 0.05 and **p ≤ 0.01) from their respective control (NTC or LPSE.coli , respectively).
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inflammasomes, such as NLRP3, are composed of a sensor
protein that can recruit caspase-1 activating machinery, usually
via the adaptor molecule ASC [Apoptosis-associated speck-like
protein containing a caspase recruitment domain (CARD)].
During inflammasome activation, spatial re-localization of ASC
into punctate structures has been described in response to
stimuli (43, 44). To evaluate if BpOMVs promote ASC speck
formation, THP1-ASC-GFP cells were stimulated with BpOMVs.
The number of specks in BpOMVs-treated cells was significantly
(p ≤ 0.05) higher than NTC under same conditions (Figure 2A),
indicating that BpOMVs can trigger ASC complex assembly.
The relation of GFP-ASC-speck-positive to total cells triggered
by BpOMVs was similar to positive control condition (Ctrl+:
LPSE.coli primed and transfected with pcDNA as suggested
by manufacturer). Representative pictures are shown with
white arrowheads indicating GFP-specks (Figure 2B). hIL1-
β, hIL-18, and hIL-8 secretion in THP1-ASC-GFP cells was
stimulated by BpOMVs (Figure 2C, p ≤ 0.05). Together, these
results showed that for BpOMVs-dependent inflammasome
activation, features such as potassium efflux and ASC speck
formation in mice BMDMs and in a human monocytic cell line
(respectively) are involved. Moreover, we confirmed that the first
of the two-steps inflammasome activation model depends on
Myd88 adaptor.
BpOMVs-Induced IL-1β Secretion Requires
Caspase-1/11 and NLRP3
As mentioned, ASC is an adaptor protein for NLRP3
inflammasome (and several other sensors), associated to
canonical activation that bridges different signals to caspase-1
activation and IL-1β cleavage (40, 45–47). We decided to
assess whether NLRP3 is involved in BpOMVs-triggered IL-1β
secretion. To this aim, C57BL/6, Nlrp3−/−, and Casp1/11−/−
BMDMs were stimulated with BpOMVs and IL-1β secretion
was evaluated. We observed that IL-1β secretion induced
by BpOMVs was completely abolished in Nlrp3−/− and
caspase1/11−/− macrophages, whereas mTNF-α production was
unaffected (Figure 3). Additionally, we stimulated C57BL/6,
Nlrp3−/−, and Casp1/11−/− BMDMs with BpOMVs and
after ON stimulation, cell supernatants were collected and
subjected to western blotting using specific Ab against the
p20 subunit of caspase-1 and the p17 subunit of IL-1β. We
observed that Nlrp3-deficient BMDMs showed a completely loss
of caspase-1 and IL-1β activation and secretion in comparison
to C57BL/6 macrophages which were fully able to activate
caspase-1 and to process IL-1β. As a control, we stimulated
Casp1/11−/− which did not express caspase-1. In the case of
KCl pretreatment of C57BL/6 macrophages stimulated with
BpOMVs (described in the previous section), we observed
reduced levels of caspase-1 and IL-1β activation and secretion
in comparison to stimulated BMDM without pretreatment
(Supplementary Figure 2). This result shows a similar pattern
to that observed in cytokine secretion levels. Together, these
results indicate that BpOMVs trigger a NLRP3 and caspase-1/11
dependent inflammasome activation.
FIGURE 3 | IL-1β secretion triggered by BpOMVs is NLRP3 and
caspase-1/11 dependent. BMDM from C57BL/6, NLRP3−/−, and
Casp1/11−/− mice were stimulated ON with BpOMVs and mIL-1β and mTNFα
were measured in supernatants. Data show the mean ± SEM from triplicate
wells. *A result significantly different (p ≤ 0.05) than levels of untreated cells;
#a result significantly different from BpOMVs stimulated C57BL/6 BMDMs.
The Pore-Forming Protein Gasdermin-D
and caspase-11 Are Involved in
Non-canonical Inflammasome Activation
by BpOMVs
The “non-canonical” inflammasome activation has been
described as caspase-11 dependent (48). Caspase-11 directly
interacts with cytosolic LPS resulting in cell death and
inflammatory responses that also involves IL-1α (49). Caspase-1
cleaves pro-IL-1β and pro-IL-18 into its mature forms and also
cleaves gasdermin-D (GSDMD) to generate a pore-forming
fragment that targets the plasma membrane, while caspase-11
cleaves and activates GSDMD but cannot process cytokines like
pro-IL-1β and pro-IL-18 efficiently (34, 50). As IL-1β secretion
was totally abolished in Casp1/11−/− BMDM stimulated with
BpOMVs and it has been described that BpLOS is one of the
main components of BpOMVs (28), we wondered if non-
canonical inflammasome pathway was also involved in this
process. To address this question, Gsdmd−/− and Casp11−/−
BMDMs were stimulated with 800 ng/mL BpOMVs and mIL-1β
and mIL-1α secretion was measured. While mTNF-α secretion
was unaffected, mIL-1β and mIL-1α were completely abolished
in Gsdmd−/− and Casp11−/− macrophages (Figure 4A, p
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FIGURE 4 | The pore-forming protein Gasdermin D and caspase-11 are involved in inflammasome activation by BpOMVs. (A) BMDMs from C57BL/6, Casp11−/−,
and Gsdmd−/− mice were stimulated ON with BpOMVs and mIL-1β, mIL-1α, and mTNFα were measured in supernatants by ELISA. (B) BMDM from C57BL/6 were
stimulated with free or transfected BpLOS and mIL-1β, mIL-1α, and mIL-12 were measured in supernatants. Data are represented as mean ± SEM of three replicates.
*A result significantly different (p ≤ 0.05) from untreated or FuGENE only treated cells; #a result significantly different from BpOMVs stimulated C57BL/6 BMDMs.
≤ 0.05). Processed IL-1β and Caspase-1 analyzed by western
blot in Casp11−/− BMDM supernatants were also abolished
or diminished (respectively) in comparison to wild type cells
(Supplementary Figure 2).
LPS chemical structure can be described into three parts:
the most conserved lipid A moiety; a core oligosaccharide
chain; and a variable polysaccharide chain known as “O-
antigen.” With structural differences respect to other species,
B. pertussis has a penta-acylated lipid A lipooligosaccharide
that lacks an O-side chain, having in its place a non-repeating
trisaccharide (51). LOS per se from other pathogens are able to
be considered as key component responsible for both priming
and licensing of inflammasome activation inducing caspase-1
activation (52). In this context, we decided to determine the
contribution of BpLOS present in BpOMVs in inflammasome
activation. C57BL/6 primary BMDMs produced higher levels
of mIL-1β and mIL-1α in response to transfected BpLOS;
however, it does not stimulate cytokine secretion when treated
with free BpLOS. mIL-12 production was similar in both
free and transfected BpLOS treatment (Figure 4B, p ≤ 0.05).
Interestingly, BpLOS within the OMV is critical for triggering
cytosolic sensors and inflammasome activation. Therefore,
we determined whether changes in BpLOS acylation degree
might influence inflammasome activation by using BpOMVs
obtained from a mutant B. pertussis strain in LOS biosynthesis
(BpOMVsPagL). This mutant strain harbors the pagL gene from
B. bronchiseptica, which encodes a lipid A 3-deacylase, resulting
in tetra- instead of penta-acylated BpLOS on the BpOMVs
(53, 54). We confirmed that changes in BpLOS acylation
influences inflammasome activation since BpOMVsPagL induced
a lower amount of mIL-1β and mIL-1α than wild type BpOMVs
(Supplementary Figure 3). Simultaneously, Nlrp3−/− BMDM
were also stimulated with BpOMVs and BpOMVsPagL as
control, showing increased secretion of mIL-12 and impaired
secretion of mIL-1β and mIL-1α (Supplementary Figure 3).
Similar results have been described for tetra-acylated LPS from
other gram-negative bacteria such as F. novicida and Y. pestis
(55, 56), indicating that caspase-11 specificity for LPS depends
on LPS acylation degree. These results indicate that caspase-
11 is required for non-canonical inflammasome activation by
BpOMVs, and that penta-acylated BpLOS is a key signal to trigger
this response.
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NLRP3, Caspase-1/11, and GSDMD Are
Involved in Inflammasome Activation by
Cytoplasmatic LOS From B. pertussis
In order to confirm the direct contribution of the cytosolic
BpLOS in non-canonical inflammasome activation, C57BL/6,
Nlrp3−/−, Casp1/11−/−, Casp11−/−, and Gsdmd−/− BMDMs
were transfected with BpLOS. mIL-1β and mIL-1α secretion
was significantly diminished in all cases compared to C57BL/6
(Figure 5, p ≤ 0.05, upper panels), while levels of mIL-12 and
mTNFα were equivalent in all treatments (Figure 5, p ≤ 0.05,
lower panels). So far, these results indicate that BpOMVs can
activate caspase-11 and that LOS-derived from outer membrane
vesicles that reach the cytosol upon endocytosis, is an important
molecular signal that triggers inflammasome activation. Taken
together these results show that BpLOS from BpOMVs is at least
one of the components involved in inflammasome activation and
that this process is dependent on NLRP3, caspase-1, caspase-11,
and GSDMD.
Guanylate-Binding Proteins Expression Is
Induced by BpOMVs and BpLOS
Previous reports suggest that caspase-11 activation during LPS
transfection requires Guanylate-binding proteins (GBPs) family
members, and that GBP2, in particular, play an important
role in this process (20, 57). The chromosomal deletion in
GBPchr3 KO mice inactivates 5 GBP genes, namely Gbp1,
Gbp2, Gbp3, Gbp5, and Gbp7. Cells lacking Gbpchr3 exhibit
a retarded caspase-11 activation and lower levels of LPS–
caspase-11 interaction, suggesting that they modulate the access
of caspase-11 to LPS (57, 58). In order to determine a
possible role for GBPs in BpOMVs inflammasome activation,
C57BL/6 BMDMs were transfected with BpLOS or stimulated
with BpOMVs or free BpLOS, and GBPs mRNA expression
levels were compared. GBP1, GBP2, GBP3, and GBP5 mRNA
expression levels increased in all treatment but were higher
when BpLOS was transfected with FuGENE into cells. GBP7
mRNA expression levels increased exclusively with transfected
FIGURE 5 | Cytosolic BpLOS contributes to non-canonical inflammasome activation. BMDM from C57BL/6, NLRP3−/−, Casp1/11−/−, Casp11−/−, and Gsdmd−/−
mice were stimulated ON with transfected BpLOS and mIL-1β, mIL-1α, mIL12p40, and mTNFα were measured in supernatants. Data are represented as mean ±
SEM of three replicates. *A result significantly different (p ≤ 0.05) from FuGENE only treated cells; #a result significantly different from FuGENE + BpLOS stimulated
C57BL/6 BMDMs.
Frontiers in Immunology | www.frontiersin.org 8 August 2020 | Volume 11 | Article 1879
Elizagaray et al. Inflammasome Activation by BpOMVs
FIGURE 6 | GBPs from chromosome 3 are involved in inflammasome activation triggered by BpOMVs and transfected BpLOS. (A) BMDMs from C57BL/6 mice were
stimulated ON with BpOMVs and with free or transfected BpLOS and expression levels of GBP1, GBP2, GBP3, GBP5, and GBP7 mRNA were measured. Data are
represented as mean ± SEM of three replicates. *, **, and *** represent a result significantly different 0.05, p ≤ 0.01 and p ≤ 0.001, respectively from NTC. (B) BMDM
from C57BL/6 and GBPchr3−/− mice were stimulated ON with BpOMVs or transfected BpLOS and mIL-1β mIL-1α and mTNFα were measured in supernatants.
*represents a result significantly different (p ≤ 0.05) from untreated or FuGENE only treated cells; #a result significantly different from BpOMVs stimulated or BpLOS
transfected C57BL/6 BMDMs.
BpLOS (Figure 6A). Furthermore, C57BL/6 and GBPchr3
KO BMDMs were stimulated with BpOMVs or transfected
BpLOS to evaluate inflammasome activation. IL-1β and IL-
1α secretion induced by BpOMVs or transfected BpLOS
was diminished in Gbpchr3−/− macrophages while mTNFα
levels were equivalent (Figure 6B, p ≤ 0.05). Same results
were observed for mIL-12 levels between both types of cells
(Supplementary Figure 4). In addition, processed IL-1β and
Caspase-1 analyzed by western blot in GBPchr3−/− BMDM
supernatants were also abolished or diminished (respectively) in
comparison to wild type cells (Supplementary Figure 2). These
observations demonstrate that GBPs play an important role in
the induction of inflammasome activation by BpOMVs, possibly
by facilitating the accessibility of BpLOS to cytosolic sensors such
as caspase-11.
DISCUSSION
The importance of inflammasomes in host defense is well-
established, acting as critical innate immune components that
orchestrate host immune homeostasis (59, 60). Inflammasome
activation is described as a two-step procedure: first, it must be
primed, and then it can be activated (42). The expression of the
inflammasome components NLRP3, caspase-1, and pro-IL-1β is
upregulated after priming and this transcriptional upregulation
can be induced through the recognition of various PAMPs
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or DAMPs that engage receptors such as TLRs or NOD2 or
through TNF-α cytokines that lead to NF-κB activation and
gene transcription (40). MyD88 adaptor is implicated in the
signaling downstream of TLRs and overexpression of MyD88
leads to spontaneous activation of NFκB (61, 62). In this
study, we have shown that BpOMVs are capable to induce
inflammasome priming and activation of human and murine
macrophages giving the increased levels of IL-1β cytokine
secretion observed. Even in the absence of LPSE.coli as priming
stimulus, BpOMVs are able to induce the secretion of IL-1β.
Furthermore, we observed that this effect is partially blocked by
inhibition of K+ efflux, indicating the participation of NLRP3
inflammasome, a signaling platform that can be activated by
multiple upstream events including ions efflux such as K+,
Cl−, Ca2+, lysosomal disruption, mitochondrial dysfunction,
metabolic changes, and trans-Golgi disassembly (41). NLRP3
inflammasome assembly leads to caspase-1-dependent release
of the pro-inflammatory cytokines IL-1β and IL-18, as well
as to gasdermin-D-mediated membrane permeabilization and
pyroptotic cell death (19). This study was focused on viable cells
that release IL-1β along with other proinflammatory cytokines,
thus the process of pyroptosis may have a marginal contribution.
The secretion of IL-1β is an unequivocal signal of inflammasome
activation and in this work IL-1β detection by western blot and
ELISA techniques confirmed the presence of mature IL-1β in
cell supernatants following BpOMVs treatment. Inflammasome
activation was also visually confirmed by fluorescent GFP-
ASC “speck” oligomerization in macrophages, a hallmark of
canonical inflammasome assembly. A recent study demonstrated
that OMVs from EHEC (enterohemorrhagic E. coli) deliver LPS
into the host cell cytosol by an unknown mechanism, resulting
in the activation of the pro-inflammatory LPS sensor caspase-
11 (7). Previously, our group has described that BpLOS in
BpOMVs influences its biological activity (53). Herein, we have
shown that intracellular BpLOS is sensed by caspase-11 and
that BpOMVs trigger non-canonical inflammasome activation. A
possible mediator of the pathogen-containing vacuoles lysis and
therefore the promotion of LPS/LOS release into the cytosol are
the GBPs, which facilitate the interaction of LPS with caspase-
11 (58). We demonstrate that GBPs mRNA expression increases
after BpOMVs and transfected BpLOS stimulation, which may
indicate that GBPs play a role in the induction of inflammasome
activation by BpOMVs. GBPs expression depends on signals
related to interferons (57). It has been demonstrated the ability
of BpOMVs to stimulate type I and II IFNs signaling pathway
(63). Moreover, recent studies propose that isoprenylated GBPs
can associate with the surface of OMVs or with cytosolic LPS
and the factor that determines GBP recruitment is LPS itself (58).
Those findings and our own results support the mechanism by
which GBPs target foreign surfaces and confirm the role of GBPs
in intracellular detection of LPS.
Although our findings point to LOS as an important microbial
signal present in the OMVs responsible for inflammasome
activation, we cannot exclude the possibility that other
OMVs components may be additional signals to trigger other
inflammasome pathways. It has been recently shown that
different Gram-negative OMVs may vehicle bacterial DNA
to host cytosol and trigger AIM2 (Absent in Melanoma 2)
dependent inflammasomes (64, 65). AIM2 is an intracellular
dsDNA sensor that, together with ASC, forms an inflammasome
complex to activate caspase-1 and mediates the release of the
proinflammatory cytokines IL-1β and IL-18 (66, 67). The AIM2
inflammasome has been reported to be essential for host-defense
against several bacterial and viral pathogens (46). Furthermore,
it has been reported the relevance of GBPs in the AIM2 DNA
sensing during an infection model (35). Although nucleic acids
seem not to be present in BpOMVs, this issue will be addressed
in future work. IL-1β is required for efficient clearance of
B. pertussis (15). The recruitment of immune cells to local
sites of infection through the upregulation of chemokines and
cytokines has been attributed to the activating effect of IL-
1β during infection. However, studies that address the role
of the inflammasome in anti-pertussis vaccination scenario
are still scarce. Ag-specific Th17 and protective immunity
against B. pertussis were demonstrated to be promoted and
generated (respectively) by inflammasome mediated IL-1β (17).
The authors of this work demonstrated a possible role of B.
pertussis Adenylate Cyclase toxin in inducing the formation of
an active inflammasome complex, resulting in IL-1β production.
The role of IL-1β in protection against pertussis was suggested
using the murine protection model (59). The authors proposed
that the release of IL-1β can be initiated independently of
caspase 1, which has been linked to adjuvants such as aluminum
present in commercial-type vaccines (15). In the present work,
we demonstrate that the BpOMVs-based vaccine platform induce
IL-1 β secretion where NLRP3, caspase-1/11, and GSDMD are
involved in inflammasome activation. The ability of BpOMVs to
activate different inflammasome pathways can be related to the
profile of immune response elicited upon vaccination. IL-1β has
been suggested to promote the expansion of differentiated T cells
and driving murine and human Th17 priming and phenotype
stabilization (68, 69). Previously, we have demonstrated that
BpOMVs based vaccine candidate promotes the induction of
protective immunity against B. pertussis lung infection in mice.
As wP vaccine, was effective at inducing B. pertussis-specific
IFN-γ (marker of Th1 cells) and IL-17 (marker of Th17 cells)
secretion by spleen cells, and Tissue-resident memory T cells
(70) whereas the aP vaccine mainly induces IL-5 (marker of
Th2 cells) (70, 71). In the same way, it is well-established the
potency of IL-1β as an enhancer of T cell responses and the IL-
1 pathway is always taken into account in the design of new
adjuvants. Taken together the results of this study support a
model in which BpLOS from BpOMVs is sensed by caspase-
11 somehow in collaboration with GBPs from chromosome 3,
leading to GSDMD processing and membrane pore formation.
This membrane permeabilization enables potassium efflux and
consequently, lowered intracellular potassium concentration is
sensed by NLRP3 causing its complexification with ASC adaptor
protein. Caspase-1 is finally activated, which in turn cleaves pro-
IL-1β and more GSDMD, triggering IL-1β secretion and a new
loop of activation. The results presented here showed the intrinsic
capacity of BpOMVs to trigger one central pathway of innate
response activation that is expected to skew the adaptive immune
response elicited by BpOMVs vaccination.
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Supplementary Figure 1 | OMVs derived from B. pertussis (BpOMVs) triggers
IL-1β in primed and unprimed murine and human macrophages. (A) BMDM from
C57BL/6 mice were primed or not with LPSE.coli for 3 h and prior to ON BpOMVs
stimulation, cells were treated or not with 80mM KCl for 30min. mIL-1β, mTNFα,
and mIL-6 were measured in supernatants. LPSE.coli plus Nigericin was used as a
positive control. ∗A result significantly different (p ≤ 0.05) from NTC; #a result
significantly different from BpOMVs stimulation (p ≤ 0.05). (B)
THP1-XBlueTM-defMyD cells were stimulated with BpOMVs or TNFα (as positive
control) and SEAP activity was measured in supernatants indicating
MyD88-independent signaling activation. ∗A result significantly different (p ≤ 0.05)
from NTC.
Supplementary Figure 2 | BpOMVs trigger caspase-1 and IL-1β maturation. Cell
supernatants from C57BL/6 treated or not with 80mM KCl, NLRP3−/−,
Casp1/11−/− Casp11−/−, and GBPchr3−/− BMDMs were separated by
SDS-PAGE, blotted, and probed with an anti-caspase-1 p20 subunit and
anti-IL-1β p17 subunit monoclonal antibody. As loading control, cell lysates were
probed with anti-β-actin monoclonal antibody.
Supplementary Figure 3 | BpLOS acylation influences inflammasome
activation. BMDM from C57BL/6 were stimulated ON with BpOMVs or
LOS-modified BpOMVsPagL and mIL-1β, mIL1-α, and mIL-12p40 were
measured in supernatants. ∗A result significantly different (p ≤ 0.05) from NTC; #a
result significantly different from the wild type cells under similar stimulation (p ≤
0.05); a result significantly different from BpOMVs stimulation (p ≤ 0.05).
Supplementary Figure 4 | GBPs from chromosome 3 are involved in
inflammasome activation triggered by BpOMVs and transfected BpLOS. C57BL/6
and GBPchr3−/− BMDMs were stimulated with BpOMVs or transfected BpLOS
and mIL-12 levels were measured in supernatants. ∗A result significantly different
(p ≤ 0.05) from NTC or to transfection reagent FuGene treatment, respectively.
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